Results 151 to 160 of about 59,298 (301)
Unacylated ghrelin counteracts mitochondrial dysfunction and neuromuscular junction disruption in cancer cachexia. [PDF]
Ahn B +4 more
europepmc +1 more source
Reserpine and the neuromuscular junction
C, Bianchi, L, Beani
openaire +2 more sources
Abstract Purpose To determine the failure rate and identify factors associated with failure following all‐inside revision meniscal repair in patients with persistent or recurrent symptoms after primary meniscal repair. Methods This was a retrospective cohort study including 108 consecutive patients who underwent arthroscopic all‑inside revision ...
Christoffer von Essen +4 more
wiley +1 more source
Immaturity of the neuromuscular junction in spinal muscular atrophy mouse models. [PDF]
Tabares L +4 more
europepmc +1 more source
Abstract Background Childhood‐onset hyperkinetic movement disorders occur in a range of genetic conditions. Recently, there has been an increase in recognition of hyperkinetic movement disorders, mainly dystonia, chorea and dyskinesia, with monogenic conditions associated with neurodevelopmental delay (NDD) and also with developmental and epileptic ...
Hugo Morales‐Briceño +6 more
wiley +1 more source
Tongue blade neuromuscular junction defects in old F344 rats. [PDF]
Kemp JF, Sieck GC, Fogarty MJ.
europepmc +1 more source
Review of Congenital Myasthenic Syndrome Caused by Pathogenic Variants in GFPT1
ABSTRACT Glutamine:fructose‐6‐phosphate transaminase 1 (GFPT1) catalyzes the first and rate‐limiting step of the hexosamine biosynthetic pathway (HBP) to generate UDP‐GlcNAc. GFPT1 exon 9 is specifically spliced in in striated muscles, which makes a long isoform of GFPT1 (GFPT1‐L).
Kinji Ohno +5 more
wiley +1 more source
Fatigue in Myasthenia Gravis: Recent Advances and Emerging Concepts
ABSTRACT Fatigue is a common, often disabling symptom in myasthenia gravis (MG), distinct from muscle fatigability, and strongly associated with reduced quality of life. This narrative review examines current evidence on fatigue in MG, its patient impact, and future research directions. Earlier studies, mostly small and heterogeneous, reported a highly
Yvonne J. M. Campman +3 more
wiley +1 more source
ABSTRACT Congenital myasthenic syndromes (CMS) are inherited disorders caused by mutations in genes encoding proteins essential for neuromuscular junction (NMJ) function. Pathogenic variants have been identified in more than 35 genes, underscoring the complexity of synaptic biology and the wide range of mechanisms that can compromise neuromuscular ...
Rocio‐Nur Villar‐Quiles +5 more
wiley +1 more source

